Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma’s ...
(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...
The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...
Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...
A new study published in the Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation shows how an innovative phone-based inhaler education program helped Medicare Advantage ...
AI-powered app Aide offers daily support for long-term conditions across Warrington GP surgeries, aiming to cut avoidable appointments and ...
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the first quarter of 2026 ...
A 2026 informational report on the Herz P1 Smart Oximeter fingertip pulse oxygen monitor, covering the company's FDA 510(k) cleared positioning, ±2% SpO2 blood oxygen accuracy specifications, smart ...
About Upstream Bio Upstream Bio is a clinical-stage biotechnology company developing treatments for inflammatory diseases, ...
AeroDel’s founders, Zahir Jaffer, Shradha Sangwai and K.K.Suraj Rajan, have one common denominator: asthma. This led them to ...
Debbie Wishart passed away in January 2025 - with her family left frustrated over key issues including her death certificate ...
UK government drives forward its 150-day clinical trial target: United Kingdom Friday, April 17, 2026, 09:00 Hrs [IST] NHS patients will be able to access life-changing new treatm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results